Hofheinz RD - Search Results

1

Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer.

Kripp M, Merx K, Wirtz RM, Gaiser T, Eidt S, Schwaab J, Post S, Wenz F, Hochhaus A, Hofheinz RD, Erben P. Kripp M, et al. Among authors: hofheinz rd. Gastroenterol Res Pract. 2016;2016:3481578. doi: 10.1155/2016/3481578. Epub 2016 Aug 16. Gastroenterol Res Pract. 2016. PMID: 27610130 Free PMC article.

2

Neoadjuvant radio-chemotherapy of adenocarcinoma of the oesophagogastric junction.

Samel S, Hofheinz R, Hundt A, Sturm J, Knoll MR, Wenz F, Queisser W, Post S. Samel S, et al. Onkologie. 2001 Jun;24(3):278-82. doi: 10.1159/000055092. Onkologie. 2001. PMID: 11455222 English, German.

3

Malignant intestinal non-Hodgkin's lymphoma from the surgical point of view.

Samel S, Wagner J, Hofheinz R, Sturm J, Post S. Samel S, et al. Onkologie. 2002 Jun;25(3):268-71. doi: 10.1159/000064321. Onkologie. 2002. PMID: 12119462

4

Irinotecan and capecitabine as second-line treatment after failure for first-line infusional 24-h 5-fluorouracil/folinic acid in advanced colorectal cancer: a phase II study.

Hofheinz RD, Gnad-Vogt U, Wein A, Saussele S, Kreil S, Pilz L, Hehlmann R, Hochhaus A. Hofheinz RD, et al. Anticancer Drugs. 2005 Jan;16(1):39-45. doi: 10.1097/00001813-200501000-00005. Anticancer Drugs. 2005. PMID: 15613902 Clinical Trial.

5

Phase I trial of capecitabine and weekly irinotecan in combination with radiotherapy for neoadjuvant therapy of rectal cancer.

Hofheinz RD, von Gerstenberg-Helldorf B, Wenz F, Gnad U, Kraus-Tiefenbacher U, Müldner A, Hehlmann R, Post S, Hochhaus A, Willeke F. Hofheinz RD, et al. J Clin Oncol. 2005 Mar 1;23(7):1350-7. doi: 10.1200/JCO.2005.04.171. Epub 2005 Jan 31. J Clin Oncol. 2005. PMID: 15684318 Clinical Trial.

6

Pegylated liposomal doxorubicin and mitomycin C in combination with infusional 5-fluorouracil and sodium folinic acid in the treatment of advanced gastric cancer: results of a phase II trial.

Gnad-Vogt SU, Hofheinz RD, Saussele S, Kreil S, Willer A, Willeke F, Pilz L, Hehlmann R, Hochhaus A. Gnad-Vogt SU, et al. Among authors: hofheinz rd. Anticancer Drugs. 2005 Apr;16(4):435-40. doi: 10.1097/00001813-200504000-00010. Anticancer Drugs. 2005. PMID: 15746580 Clinical Trial.

7

Liposomal encapsulated anti-cancer drugs.

Hofheinz RD, Gnad-Vogt SU, Beyer U, Hochhaus A. Hofheinz RD, et al. Anticancer Drugs. 2005 Aug;16(7):691-707. doi: 10.1097/01.cad.0000167902.53039.5a. Anticancer Drugs. 2005. PMID: 16027517 Review.

8

Expression of the mutated transketolase TKTL1, a molecular marker in gastric cancer.

Staiger WI, Coy JF, Grobholz R, Hofheinz RD, Lukan N, Post S, Schwarzbach MH, Willeke F. Staiger WI, et al. Among authors: hofheinz rd. Oncol Rep. 2006 Oct;16(4):657-61. Oncol Rep. 2006. PMID: 16969476

9

Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer.

Hofheinz RD, Horisberger K, Woernle C, Wenz F, Kraus-Tiefenbacher U, Kähler G, Dinter D, Grobholz R, Heeger S, Post S, Hochhaus A, Willeke F. Hofheinz RD, et al. Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1384-90. doi: 10.1016/j.ijrobp.2006.07.005. Epub 2006 Sep 18. Int J Radiat Oncol Biol Phys. 2006. PMID: 16979839 Clinical Trial.

10

Gefitinib in combination with 5-fluorouracil (5-FU)/folinic acid and irinotecan in patients with 5-FU/oxaliplatin- refractory colorectal cancer: a phase I/II study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO).

Hofheinz RD, Kubicka S, Wollert J, Arnold D, Hochhaus A. Hofheinz RD, et al. Onkologie. 2006 Dec;29(12):563-7. doi: 10.1159/000096449. Epub 2006 Dec 11. Onkologie. 2006. PMID: 17202826 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page